Insights

Acquisition Impact Cylica has been acquired by Recursion (Nasdaq RXRX), signaling a strategic pivot and potential expansion opportunities in AI-driven biotech workflows and CRO partnerships. This presents a chance to engage on cross-platform collaboration, data integration, and expanded service offerings with Recursion’s ecosystem.

Financial Momentum Beacons AI revenues reached significant milestones in 2024, with reported figures of 6M to 10.8M and a total funding of 26M. This indicates a growing customer base and willingness to invest in Link-in-Bio and creator monetization tools, suggesting sales opportunities in scale-up features, enterprise licenses, and premium analytics.

Tech Stack Affinities Core technologies include Google Cloud, PostgreSQL, Sentry, and Google Ads, which align with BI, data management, and cloud-based analytics needs. Prospects may benefit from upsell of cloud-native solutions, data security enhancements, and managed services that complement existing infrastructure.

Market Positioning Beacons operates in the creator economy tooling space with competitors like Linkpop and Linktree, indicating a crowded market but with strong demand for monetization and affiliate marketplace capabilities. Opportunities exist for integrated marketing partnerships, affiliate networks, and white-label solutions targeted at brands and creators.

Strategic Fit With Beacons expanding into Beacons for Brands and affiliate marketplaces, there is potential to propose B2B partnerships, enterprise onboarding, and joint go-to-market initiatives that leverage Recursion’s biotech footprint, combined data capabilities, and existing investor exposure to accelerate growth.

Similar companies to Cyclica (acquired by Recursion, Nasdaq: RXRX)

Cyclica (acquired by Recursion, Nasdaq: RXRX) Tech Stack

Cyclica (acquired by Recursion, Nasdaq: RXRX) uses 8 technology products and services including Google Ads, Weebly, PostgreSQL, and more. Explore Cyclica (acquired by Recursion, Nasdaq: RXRX)'s tech stack below.

Cyclica (acquired by Recursion, Nasdaq: RXRX)'s Email Address Formats

Cyclica (acquired by Recursion, Nasdaq: RXRX) uses at least 4 email formats:
Cyclica (acquired by Recursion, Nasdaq: RXRX) Email FormatsExamplePercentage
First.Last@cyclicarx.comJohn.Doe@cyclicarx.com
100%
First@beacons.aiJohn@beacons.ai
85%
Last@beacons.aiDoe@beacons.ai
14%
FirstL@beacons.aiJohnD@beacons.ai
1%

Frequently Asked Questions

What is Cyclica (acquired by Recursion, Nasdaq: RXRX)'s phone number?

Minus sign iconPlus sign icon
You can contact Cyclica (acquired by Recursion, Nasdaq: RXRX)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cyclica (acquired by Recursion, Nasdaq: RXRX)'s stock symbol?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX) is a publicly traded company; the company's stock symbol is PEZ.

What is Cyclica (acquired by Recursion, Nasdaq: RXRX)'s official website and social media links?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s official website is beacons.ai and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cyclica (acquired by Recursion, Nasdaq: RXRX) generate?

Minus sign iconPlus sign icon
As of August 2026, Cyclica (acquired by Recursion, Nasdaq: RXRX)'s annual revenue is estimated to be $1M - $10M.

What is Cyclica (acquired by Recursion, Nasdaq: RXRX)'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cyclica (acquired by Recursion, Nasdaq: RXRX) have currently?

Minus sign iconPlus sign icon
As of August 2026, Cyclica (acquired by Recursion, Nasdaq: RXRX) has approximately 4 employees across 1 continents, including North America. Key team members include Head Of Business Development Operations: C. S. and Founder: J. M. Explore Cyclica (acquired by Recursion, Nasdaq: RXRX)'s employee directory with LeadIQ.

What industry does Cyclica (acquired by Recursion, Nasdaq: RXRX) belong to?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX) operates in the Biotechnology Research industry.

What technology does Cyclica (acquired by Recursion, Nasdaq: RXRX) use?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s tech stack includes Google Ads, Weebly, PostgreSQL, Google Cloud, Sentry, HighLevel, Trustpilot and Zoom.

What is Cyclica (acquired by Recursion, Nasdaq: RXRX)'s email format?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s email format typically follows the pattern of First.Last@cyclicarx.com. Find more Cyclica (acquired by Recursion, Nasdaq: RXRX) email formats with LeadIQ.

How much funding has Cyclica (acquired by Recursion, Nasdaq: RXRX) raised to date?

Minus sign iconPlus sign icon
As of August 2026, Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised $26M in funding. The last funding round occurred on Dec 15, 2022 for $1.8M.

When was Cyclica (acquired by Recursion, Nasdaq: RXRX) founded?

Minus sign iconPlus sign icon
Cyclica (acquired by Recursion, Nasdaq: RXRX) was founded in 2013.
Cyclica (acquired by Recursion, Nasdaq: RXRX) logo

Cyclica (acquired by Recursion, Nasdaq: RXRX)

Biotechnology ResearchOntario, Canada2-10 Employees

Cyclica is a biotechnology research company based in Toronto, Ontario, Canada. It has been acquired by Recursion, a Nasdaq-listed company (RXRX). The company lists Beacons.ai as its website.

The organization is described as having a small team. The available information does not specify its products, customers, or market segments, but it places Cyclica within the broader biotechnology research sector.

Section iconCompany Overview

Phone number
Website
beacons.ai
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
PEZ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $26M

    Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $26M of funding over 8 rounds. Their latest funding round was raised on Dec 15, 2022 in the amount of $1.8M as a Grant.

  • $1M - $10M

    Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.